HKSE - Delayed Quote HKD

Shanghai Henlius Biotech, Inc. (2696.HK)

Compare
21.450 -0.350 (-1.61%)
As of November 5 at 4:08 PM GMT+8. Market Open.
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
9,903,571.000
8,924,308.000
7,172,844.000
6,439,176.000
Total Liabilities Net Minority Interest
7,711,270.000
7,287,976.000
4,876,088.000
3,240,404.000
Total Equity Gross Minority Interest
2,192,301.000
1,636,332.000
2,296,756.000
3,198,772.000
Total Capitalization
3,298,520.000
2,611,625.000
3,130,456.000
3,622,969.000
Common Stock Equity
2,192,301.000
1,636,332.000
2,296,756.000
3,198,772.000
Capital Lease Obligations
273,416.000
261,092.000
292,750.000
292,975.000
Net Tangible Assets
-2,318,428.000
-2,695,951.000
-1,338,175.000
256,318.000
Working Capital
-2,391,401.000
-2,810,036.000
-1,312,566.000
-69,514.000
Invested Capital
6,011,936.000
5,052,335.000
4,626,943.000
4,739,414.000
Tangible Book Value
-2,318,428.000
-2,695,951.000
-1,338,175.000
256,318.000
Total Debt
4,093,051.000
3,677,095.000
2,622,937.000
1,833,617.000
Net Debt
2,831,970.000
2,735,525.000
2,175,205.000
426,333.000
Share Issued
543,494.853
543,494.853
543,494.853
543,494.853
Ordinary Shares Number
543,494.853
543,494.853
543,494.853
543,494.853
12/31/2020 - 9/25/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers